Treatment & Vaccine

The clinical trials for the vaccine candidates of AstraZeneca and Johnson & Johnson got back on track in the United States.

AstraZeneca, Johnson & Johnson Vaccine Trials to Resume in the US 

Bharat Biotech’s ‘Covaxin’ Expected to Be Launched by June 2021

An official from India’s Bharat Biotech has said that its COVID-19 vaccine candidate, Covaxin, may be ready by June 2021.

Special Immunisation Programme for COVID-19 Vaccine 

India is now at the forefront of vaccine development for Covid-19, Prime Minister Narendra Modi said on Monday.

61% Indians Skeptical About COVID-19 Vaccine, Finds a Survey

Only 12% respondents would get vaccinated and go back to living pre-COVID lifestyle, while 25% said they will get vaccinated but still will not go back. 10% said they will not take it at all in 2021.

COVID Vaccine to Be Ready for All Americans by April 2021: US Govt

“By the end of January, enough vaccine for all of our seniors as well as our health care workers and first responders.”

Serum, IAVI & Merck To Build SARS-CoV-2 Monoclonal Antibodies

The companies have broad networks across complementary geographic areas that will be crucial to reach given the worldwide spread of Covid-19.

Is Tocilizumab another failed ‘magic bullet’ or do we need more clinical trials and studies to know?

New Studies Say Tocilizumab May be Ineffective Against COVID-19

Plasma Therapy Doesn't Reduce COVID Mortality: ICMR Study in BMJ

Remdesivir Becomes 1st FDA-Approved COVID-19 Treatment in the US

Anika Chebrolu’s invention uses in-silico methodology for drug discovery to find a molecule that can selectively bind to the spike protein of the SARS-CoV-2 virus

Teenager Anika Chebrolu Wins $25K for Work on COVID-19 Treatment

COVID-19 Vaccine Tracker: These Candidates Are Still on Track

Explained: What is IIT Kharagpur’s ‘COVIRAP’ Diagnostic Test? 

The clinical trials for the vaccine candidates of AstraZeneca and Johnson & Johnson got back on track in the United States.

AstraZeneca, Johnson & Johnson Vaccine Trials to Resume in the US 

Bharat Biotech’s ‘Covaxin’ Expected to Be Launched by June 2021

An official from India’s Bharat Biotech has said that its COVID-19 vaccine candidate, Covaxin, may be ready by June 2021.

Special Immunisation Programme for COVID-19 Vaccine 

India is now at the forefront of vaccine development for Covid-19, Prime Minister Narendra Modi said on Monday.
Only 12% respondents would get vaccinated and go back to living pre-COVID lifestyle, while 25% said they will get vaccinated but still will not go back. 10% said they will not take it at all in 2021.

61% Indians Skeptical About COVID-19 Vaccine, Finds a Survey

COVID Vaccine to Be Ready for All Americans by April 2021: US Govt

“By the end of January, enough vaccine for all of our seniors as well as our health care workers and first responders.”

Serum, IAVI & Merck To Build SARS-CoV-2 Monoclonal Antibodies

The companies have broad networks across complementary geographic areas that will be crucial to reach given the worldwide spread of Covid-19.
Is Tocilizumab another failed ‘magic bullet’ or do we need more clinical trials and studies to know?

New Studies Say Tocilizumab May be Ineffective Against COVID-19

Plasma Therapy Doesn't Reduce COVID Mortality: ICMR Study in BMJ

ICMR's Blood Plasma Therapy trial results have been published in British Medical Journal.

Remdesivir Becomes 1st FDA-Approved COVID-19 Treatment in the US

US FDA approves use of Remdesivir as COVID-19 treatment.
Anika Chebrolu’s invention uses in-silico methodology for drug discovery to find a molecule that can selectively bind to the spike protein of the SARS-CoV-2 virus

Teenager Anika Chebrolu Wins $25K for Work on COVID-19 Treatment

COVID-19 Vaccine Tracker: These Candidates Are Still on Track

Currently, 198 vaccine candidates are in several stages of clinical research according to the WHO.

Explained: What is IIT Kharagpur’s ‘COVIRAP’ Diagnostic Test? 

The World Health Organisation cautioned against any relaxation of response actions following the recent slight decline in Covid-19 cases.